Genetic Testing Prevalence, Guidelines, and Pitfalls in Large, University-Based Medical Systems
- 1 January 2021
- journal article
- editorial
- Published by SLACK, Inc. in Ophthalmic Surgery, Lasers and Imaging Retina
- Vol. 52 (1), 6-10
- https://doi.org/10.3928/23258160-20201223-02
Abstract
Ophthalmic Surgery, Lasers and Imaging Retina | Seenu M. HariprasadPractical Retina Co-Editor Medical history was made in the fall of 2015 when Spark's SPK-RPE65 phase 3 U.S. Food and Drug Administration (FDA) registration trial showed gains in functional vision and light sensitivity in certain patients with inherited retinal dystrophies (IRDs) such as Leber'sThis publication has 6 references indexed in Scilit:
- Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy developmentExpert Opinion on Biological Therapy, 2020
- Public Views on Genetics and Genetic Testing: A Survey of the General Public in BelgiumGenetic Testing and Molecular Biomarkers, 2017
- Navigating the current landscape of clinical genetic testing for inherited retinal dystrophiesGenetics in Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Panel-based genetic diagnostic testing for inherited eye diseases is highly accurate and reproducible, and more sensitive for variant detection, than exome sequencingGenetics in Medicine, 2014
- Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinementsHuman Genetics, 2013